Literature DB >> 7829248

Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines.

J J van Groningen1, S L Klink, H P Bloemers, G W Swart.   

Abstract

In this study the relationship between tissue-type transglutaminase (TGase2) activity and the propensity to metastasize was investigated in human melanoma cell lines with different metastatic behavior. TGase2 catalyzes an acyl-transfer reaction between peptide-bound glutamine residues and primary amines, including the epsilon-amino group of lysine residues. Northern-blot analysis demonstrated that TGase2 RNA-expression (3.7 kb) was elevated in highly metastatic cell lines (MV3 and BLM) as compared to weakly metastatic ones (IF6 and 530). Immunoprecipitation and enzyme assays of TGase2 showed that the differential expression at the mRNA level was also reflected at the protein level. These findings reveal a positive relation between the expression of TGase2 and the metastatic properties of the human melanoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829248     DOI: 10.1002/ijc.2910600319

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Expression signatures of early-stage and advanced medaka melanomas.

Authors:  Barbara Klotz; Susanne Kneitz; Martina Regensburger; Lena Hahn; Michael Dannemann; Janet Kelso; Birgit Nickel; Yuan Lu; William Boswell; John Postlethwait; Wesley Warren; Manfred Kunz; Ronald B Walter; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-11-21       Impact factor: 3.228

2.  Serum biomarker panels for the detection of pancreatic cancer.

Authors:  Randall E Brand; Brian M Nolen; Herbert J Zeh; Peter J Allen; Mohamad A Eloubeidi; Michael Goldberg; Eric Elton; Juan P Arnoletti; John D Christein; Selwyn M Vickers; Christopher J Langmead; Douglas P Landsittel; David C Whitcomb; William E Grizzle; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

Review 3.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

Review 4.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

5.  Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.

Authors:  S S Akimov; D Krylov; L F Fleischman; A M Belkin
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.